AEON – aeon biopharma, inc. class a (US:NASDAQ)
Stock Stats
News
AEON Biopharma Reports BPD Type 2a Meeting with FDA and Shareholder Approval of the November Transactions
AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711
AEON Biopharma Announces Execution of Exchange Agreement with Daewoong
AEON Biopharma Announces First Closing of PIPE Investment and Provides Update on FDA Type 2a Meeting Scheduling
AEON Biopharma (NASDAQ:AEON) was upgraded by analysts at HC Wainwright to a "strong-buy" rating.
Form S-3 AEON Biopharma, Inc.
Form 3 AEON Biopharma, Inc. For: Jan 21 Filed by: Daewoong Co., Ltd
Form SCHEDULE 13D AEON Biopharma, Inc. Filed by: Daewoong Co., Ltd
Form SCHEDULE 13D/A AEON Biopharma, Inc. Filed by: Daewoong Co., Ltd
Form 8-K AEON Biopharma, Inc. For: Jan 21
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.